HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yin-lian Wu Selected Research

Chronic Hepatitis B

3/2015Hepatitis B surface antigen in late hepatitis B infection.
10/2012[Prolonged duration of the routine pegylated-interferon alfa-2a therapy produces superior virological response in HBeAg-positive chronic hepatitis B patients: a single-center cohort study].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yin-lian Wu Research Topics

Disease

2Chronic Hepatitis B
03/2015 - 10/2012
1Hepatitis B
03/2015
1Hepatitis E
03/2015
1Persistent Infection
03/2015
1Fibrosis (Cirrhosis)
03/2015
1Hepatocellular Carcinoma (Hepatoma)
03/2015
1Infections
03/2015
1Liver Cirrhosis (Hepatic Cirrhosis)
03/2015

Drug/Important Bio-Agent (IBA)

2Hepatitis B e AntigensIBA
03/2015 - 10/2012
2Hepatitis B Surface Antigens (HBsAg)FDA Link
03/2015 - 10/2012
1DNA (Deoxyribonucleic Acid)IBA
03/2015
1peginterferon alfa-2a (Pegasys)FDA Link
10/2012

Therapy/Procedure

1Therapeutics
10/2012